An interview with Rebecca Dent MD, Deputy Chief Executive Officer, National Cancer Centre, Singapore, ESMO 2024 Scientific Chair. ESMO Previous...
AudioMedica News Early Breast Cancer: Survival Benefit For Adjuvant Docetaxel/Cyclophosphamide Play Episode Pause Episode Mute/Unmute Episode Rewind...